Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | PLX-4720 | 1 | uM | 4 | 2500.00 | 1354.79 | 5284.00 | 4390.25 | 1.2036 | 1.2309 |
| BT-20 | PLX-4720 | 0.031623 | uM | 4 | 2500.00 | 1354.79 | 4729.00 | 4390.25 | 1.0772 | 1.0896 |
| BT-20 | 0 | uM | 4 | 2500.00 | 1354.79 | 4356.00 | 4390.25 | 0.9922 | 0.9908 | |
| BT-20 | 0 | uM | 4 | 2500.00 | 1354.79 | 3719.00 | 4390.25 | 0.8471 | 0.8136 | |
| BT-20 | 0 | uM | 4 | 2500.00 | 1354.79 | 3711.00 | 4390.25 | 0.8453 | 0.8113 | |
| BT-20 | 0 | uM | 4 | 2500.00 | 1354.79 | 3818.00 | 4390.25 | 0.8697 | 0.8419 | |
| BT-20 | Etoposide | 0.01 | uM | 4 | 2500.00 | 1354.79 | 3949.00 | 4390.25 | 0.8995 | 0.8789 |
| BT-20 | Etoposide | 0.31623 | uM | 4 | 2500.00 | 1354.79 | 3343.00 | 4390.25 | 0.7615 | 0.7032 |
| BT-20 | PLX-4720 | 0.1 | uM | 4 | 2500.00 | 1354.79 | 4607.00 | 4390.25 | 1.0494 | 1.0576 |
| BT-20 | Nilotinib | 0.01 | uM | 4 | 2500.00 | 1354.79 | 4685.00 | 4390.25 | 1.0671 | 1.0781 |
| BT-20 | Nilotinib | 0.1 | uM | 4 | 2500.00 | 1354.79 | 4503.00 | 4390.25 | 1.0257 | 1.0301 |
| BT-20 | Etoposide | 19.9526 | uM | 4 | 2500.00 | 1354.79 | 991.00 | 4390.25 | 0.2257 | -0.1684 |
| BT-20 | PLX-4720 | 0.01 | uM | 4 | 2500.00 | 1354.79 | 4906.00 | 4390.25 | 1.1175 | 1.1353 |
| BT-20 | PLX-4720 | 3.1623 | uM | 4 | 2500.00 | 1354.79 | 4722.00 | 4390.25 | 1.0756 | 1.0878 |
| BT-20 | Nilotinib | 10 | uM | 4 | 2500.00 | 1354.79 | 1409.00 | 4390.25 | 0.3209 | 0.0234 |
| BT-20 | NVP-TAE684 | 0.0016596 | uM | 4 | 2500.00 | 1354.79 | 4794.00 | 4390.25 | 1.0920 | 1.1065 |
| BT-20 | Nilotinib | 1 | uM | 4 | 2500.00 | 1354.79 | 4757.00 | 4390.25 | 1.0835 | 1.0969 |
| BT-20 | NVP-TAE684 | 0.1 | uM | 4 | 2500.00 | 1354.79 | 4996.00 | 4390.25 | 1.1380 | 1.1584 |
| BT-20 | PLX-4720 | 10 | uM | 4 | 2500.00 | 1354.79 | 4184.00 | 4390.25 | 0.9530 | 0.9441 |
| BT-20 | Nilotinib | 19.9526 | uM | 4 | 2500.00 | 1354.79 | 1812.00 | 4390.25 | 0.4127 | 0.1870 |
| BT-20 | 0 | uM | 4 | 2500.00 | 1354.79 | 4819.00 | 4390.25 | 1.0977 | 1.1129 | |
| BT-20 | NVP-TAE684 | 3.1623 | uM | 4 | 2500.00 | 1354.79 | 2319.00 | 4390.25 | 0.5282 | 0.3728 |
| BT-20 | Etoposide | 0.0033113 | uM | 4 | 2500.00 | 1354.79 | 4544.00 | 4390.25 | 1.0350 | 1.0410 |
| BT-20 | PLX-4720 | 19.9526 | uM | 4 | 2500.00 | 1354.79 | 2881.00 | 4390.25 | 0.6562 | 0.5602 |
| BT-20 | Etoposide | 3.1623 | uM | 4 | 2500.00 | 1354.79 | 1657.00 | 4390.25 | 0.3774 | 0.1260 |